Recently, the first project roadshow of the 26th Haichuang Week "Haichuang Project" was held online. Six high-level talent teams gathered in the "cloud". The projects covered strategic emerging industries such as software and information technology, intelligent manufacturing, life and health. The high level of the talent team participating in this roadshow and the distinctive "high-tech" level of the participating projects attract people's attention.

With the two-wheel drive mode of "technological breakthrough + scene application", in this roadshow there were six high-quality projects with sufficient scientific and technological innovation content, high fit of industrial development and good future development prospects: they are 2,000 tons/year electronic-grade hydrogen chloride, PCB board brazing robot and its industrialization, R&D and industrialization of paralyzed limb motor function reconstruction instrument, intelligent remote ultrasonic diagnosis, R&D and industrialization of two-way drive visual inspection products, core materials and devices of nonlinear up-conversion infrared detector respectively.

In this roadshow, the project presents three common characteristics. First, it has a high level of personnel, rich technical experience, and the project leaders are all doctors; The second is that the projects mastered the core patented technology, which can realize import substitution. Among them, the 2,000 tons/year electronic-grade hydrogen chloride project has mastered the key core technology in the field of distillation and purification technology. The application of this technology is not limited to hydrogen chloride, but is also applicable to many other product areas that require extremely high purity; Third, the projects have been accepted by the market, and some of them have been mass-produced. The microelectronic nerve bridge rehabilitation technology adopted in the R&D and industrialization project of the paralyzed limb motor function reconstruction instrument has shown remarkable innovation ability and advancement. The effectiveness and industrialization potential of the myoelectric bridge limb movement instrument developed by the company in clinical application have been preliminarily verified by the market, and its application potential in the downstream market is also extremely broad. Five major investment institutions, including Tianyi Capital and Shenzhen Venture Capital, formed a "super jury" to take the pulse of the project, and conducted in-depth analysis and evaluation of the roadshow project from multiple dimensions such as technical barriers, industry track prospects, product competitiveness, and team configuration. They provided professional comments and guidance on the investment value of the project.